A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

Lee Schwartzberg, Timothy Rearden, Lorrin Yee, Barry Mirtsching, Veena Charu, Hung Lam, Tom Lillie, Ronald Burkes, Peter Silberstein

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)22-23
Number of pages2
JournalJournal of Supportive Oncology
Volume5
Issue number4 SUPPL. 2
StatePublished - Apr 2007

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia. / Schwartzberg, Lee; Rearden, Timothy; Yee, Lorrin; Mirtsching, Barry; Charu, Veena; Lam, Hung; Lillie, Tom; Burkes, Ronald; Silberstein, Peter.

In: Journal of Supportive Oncology, Vol. 5, No. 4 SUPPL. 2, 04.2007, p. 22-23.

Research output: Contribution to journalArticle

Schwartzberg, L, Rearden, T, Yee, L, Mirtsching, B, Charu, V, Lam, H, Lillie, T, Burkes, R & Silberstein, P 2007, 'A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia', Journal of Supportive Oncology, vol. 5, no. 4 SUPPL. 2, pp. 22-23.
Schwartzberg, Lee ; Rearden, Timothy ; Yee, Lorrin ; Mirtsching, Barry ; Charu, Veena ; Lam, Hung ; Lillie, Tom ; Burkes, Ronald ; Silberstein, Peter. / A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia. In: Journal of Supportive Oncology. 2007 ; Vol. 5, No. 4 SUPPL. 2. pp. 22-23.
@article{880e7e8cf73d4b96b765a14fa9181f50,
title = "A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia",
author = "Lee Schwartzberg and Timothy Rearden and Lorrin Yee and Barry Mirtsching and Veena Charu and Hung Lam and Tom Lillie and Ronald Burkes and Peter Silberstein",
year = "2007",
month = "4",
language = "English (US)",
volume = "5",
pages = "22--23",
journal = "The journal of supportive oncology",
issn = "1544-6794",
publisher = "Biolink Communications, Inc.",
number = "4 SUPPL. 2",

}

TY - JOUR

T1 - A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

AU - Schwartzberg, Lee

AU - Rearden, Timothy

AU - Yee, Lorrin

AU - Mirtsching, Barry

AU - Charu, Veena

AU - Lam, Hung

AU - Lillie, Tom

AU - Burkes, Ronald

AU - Silberstein, Peter

PY - 2007/4

Y1 - 2007/4

UR - http://www.scopus.com/inward/record.url?scp=34250615108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250615108&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 22

EP - 23

JO - The journal of supportive oncology

JF - The journal of supportive oncology

SN - 1544-6794

IS - 4 SUPPL. 2

ER -